Increased FOXJ1 protein expression is associated with improved overall survival in high-grade serous ovarian carcinoma: an Ovarian Tumor Tissue Analysis Consortium Study

被引:3
作者
Weir, Ashley [1 ,2 ,3 ]
Kang, Eun-Young [4 ]
Meagher, Nicola S. [1 ,2 ,5 ]
Nelson, Gregg S. [6 ]
Ghatage, Prafull [6 ]
Lee, Cheng-Han [7 ]
Riggan, Marjorie J. [8 ]
Gentry-Maharaj, Aleksandra [9 ]
Ryan, Andy [9 ,10 ]
Singh, Naveena [11 ]
Widschwendter, Martin [12 ]
Alsop, Jennifer [13 ]
Anglesio, Michael S. [14 ,15 ,16 ]
Beckmann, Matthias W. [17 ]
Berger, Jessica [18 ]
Bisinotto, Christiani [19 ]
Boros, Jessica [20 ,21 ,22 ]
Brand, Alison H. [21 ,22 ]
Brenton, James D. [23 ]
Brooks-Wilson, Angela [24 ]
Carney, Michael E. [25 ]
Cunningham, Julie M. [26 ]
Cushing-Haugen, Kara L. [27 ]
Cybulski, Cezary [28 ]
Elishaev, Esther [29 ]
Erber, Ramona [30 ]
Fereday, Sian [31 ,32 ]
Fischer, Anna [33 ]
Paz-Ares, Luis [34 ,35 ]
Gayarre, Javier [36 ]
Gilks, Blake C. [37 ]
Grube, Marcel [38 ]
Harnett, Paul R. [22 ,39 ]
Harris, Holly R. [27 ,40 ]
Hartmann, Arndt [30 ]
Hein, Alexander [17 ]
Hendley, Joy [31 ]
Hernandez, Brenda Y. [41 ]
Heublein, Sabine [42 ]
Huang, Yajue [26 ]
Huzarski, Tomasz [28 ,43 ]
Jakubowska, Anna [28 ,44 ]
Jimenez-Linan, Mercedes [45 ]
Kennedy, Catherine J. [20 ,21 ,22 ]
Kommoss, Felix K. F. [46 ]
Koziak, Jennifer M. [47 ]
Kraemer, Bernhard [38 ]
Le, Nhu D. [48 ]
Lesnock, Jaime [18 ]
Lester, Jenny [49 ]
机构
[1] Univ NSW Sydney, Sch Clin Med, UNSW Med & Hlth, Sydney, NSW, Australia
[2] Univ NSW Sydney, Lowy Canc Res Ctr, Adult Canc Program, Sydney, NSW, Australia
[3] Walter & Eliza Hall Inst Med Res, Parkville, Vic, Australia
[4] Univ Calgary, Foothills Med Ctr, Dept Pathol & Lab Med, Calgary, AB, Canada
[5] Univ Sydney, Daffodil Ctr, Sydney, NSW, Australia
[6] Univ Calgary, Cumming Sch Med, Dept Oncol, Div Gynecol Oncol, Calgary, AB, Canada
[7] Univ Alberta, Dept Pathol & Lab Med, Edmonton, AB, Canada
[8] Duke Univ Med Ctr, Dept Obstet & Gynecol, Div Gynecol Oncol, Durham, NC USA
[9] UCL, Inst Clin Trials & Methodol, MRC Clin Trials Unit, London, England
[10] UCL, Inst Womens Hlth, Womens Canc, London, England
[11] Barts Hlth Natl Hlth Serv Trust, Dept Pathol, London, England
[12] Univ Innsbruck, EUTOPS Inst, Innsbruck, Austria
[13] Univ Cambridge, Ctr Canc Genet Epidemiol, Dept Oncol, Cambridge, England
[14] Univ British Columbia, Dept Obstet & Gynecol, Vancouver, BC, Canada
[15] Univ British Columbia, BC Canc, British Columbias Gynecol Canc Res Team OVCARE, Vancouver, BC, Canada
[16] Vancouver Gen Hosp, Vancouver, BC, Canada
[17] Friedrich Alexander Univ Erlangen Nuremberg, Univ Hosp Erlangen, Comprehens Canc Ctr Erlangen EMN, Dept Gynecol & Obstet, Erlangen, Germany
[18] Univ Pittsburgh, Sch Med, Dept Obstet Gynecol & Reprod Sci, Div Gynecol Oncol, Pittsburgh, PA USA
[19] Univ Sao Paulo, Ribeirao Preto Med Sch, Dept Gynecol & Obstet, Ribeirao Preto, Brazil
[20] Univ Sydney, Ctr Canc Res, Westmead Inst Med Res, Sydney, NSW, Australia
[21] Westmead Hosp, Dept Gynaecol Oncol, Sydney, NSW, Australia
[22] Univ Sydney, Sydney, NSW, Australia
[23] Univ Cambridge, Canc Res UK Cambridge Inst, Cambridge, England
[24] BC Canc, Canadas Michael Smith Genome Sci Ctr, Vancouver, BC, Canada
[25] Univ Hawaii, John A Burns Sch Med, Dept Obstet & Gynecol, Honolulu, HI 96822 USA
[26] Mayo Clin, Dept Lab Med & Pathol, Rochester, MN USA
[27] Fred Hutchinson Canc Res Ctr, Div Publ Hlth Sci, Program Epidemiol, 1124 Columbia St, Seattle, WA 98104 USA
[28] Pomeranian Med Univ, Int Hereditary Canc Ctr, Dept Genet & Pathol, Szczecin, Poland
[29] Univ Pittsburgh, Sch Med, Dept Pathol, Pittsburgh, PA USA
[30] Friedrich Alexander Univ Erlangen Nuremberg, Univ Hosp Erlangen, Comprehens Canc Ctr Erlangen EMN, Inst Pathol, Erlangen, Germany
[31] Peter MacCallum Canc Ctr, Melbourne, Vic, Australia
[32] Univ Melbourne, Sir Peter MacCallum Dept Oncol, Parkville, Vic, Australia
[33] Tuebingen Univ Hosp, Inst Pathol & Neuropathol, Tubingen, Germany
[34] Spanish Natl Canc Res Ctr CNIO, H12O CNIO Lung Canc Clin Res Unit, Madrid, Spain
[35] Hosp Univ 12 Octubre, Oncol Dept, Madrid, Spain
[36] Spanish Natl Canc Res Ctr CNIO, Human Genet Grp, Madrid, Spain
[37] Univ British Columbia, Dept Pathol & Lab Med, Vancouver, BC, Canada
[38] Tuebingen Univ Hosp, Dept Womens Hlth, Tubingen, Germany
[39] Westmead Hosp, Crown Princess Mary Canc Ctr, Sydney, NSW, Australia
[40] Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA
[41] Univ Hawaii Canc Ctr, Honolulu, HI USA
[42] Univ Hosp Heidelberg, Dept Obstet & Gynecol, Heidelberg, Germany
[43] Univ Zielona Gora, Dept Genet & Pathol, Zielona Gora, Poland
[44] Pomeranian Med Univ, Independent Lab Mol Biol & Genet Diagnost, Szczecin, Poland
[45] Addenbrookes Hosp, Dept Histopathol, Cambridge, England
[46] Heidelberg Univ Hosp, Inst Pathol, Heidelberg, Germany
[47] Alberta Hlth Serv Canc Care, Calgary, AB, Canada
[48] BC Canc, Canc Control Res, Vancouver, BC, Canada
[49] Univ Calif Los Angeles, David Geffen Sch Med, Dept Obstet & Gynecol, Los Angeles, CA 90095 USA
[50] Pomeranian Med Univ, Dept Gynecol Surg & Gynecol Oncol Adults & Adoles, Szczecin, Poland
基金
英国医学研究理事会; 加拿大健康研究院; 美国国家卫生研究院;
关键词
FALLOPIAN-TUBE; PAX8; EXPRESSION; CANCER; GENE; MULTIPLE; INVASION;
D O I
10.1038/s41416-022-02014-y
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background Recently, we showed a >60% difference in 5-year survival for patients with tubo-ovarian high-grade serous carcinoma (HGSC) when stratified by a 101-gene mRNA expression prognostic signature. Given the varied patient outcomes, this study aimed to translate prognostic mRNA markers into protein expression assays by immunohistochemistry and validate their survival association in HGSC. Methods Two prognostic genes, FOXJ1 and GMNN, were selected based on high-quality antibodies, correlation with protein expression and variation in immunohistochemical scores in a preliminary cohort (n = 134 and n = 80, respectively). Six thousand four hundred and thirty-four (FOXJ1) and 5470 (GMNN) formalin-fixed, paraffin-embedded ovarian neoplasms (4634 and 4185 HGSC, respectively) represented on tissue microarrays from the Ovarian Tumor Tissue Analysis consortium underwent immunohistochemical staining and scoring, then univariate and multivariate survival analysis. Results Consistent with mRNA, FOXJ1 protein expression exhibited a linear, increasing association with improved overall survival in HGSC patients. Women with >50% expression had the most favourable outcomes (HR = 0.78, 95% CI 0.67-0.91, p < 0.0001). GMNN protein expression was not significantly associated with overall HSGC patient survival. However, HGSCs with >35% GMNN expression showed a trend for better outcomes, though this was not significant. Conclusion We provide foundational evidence for the prognostic value of FOXJ1 in HGSC, validating the prior mRNA-based prognostic association by immunohistochemistry.
引用
收藏
页码:137 / 147
页数:11
相关论文
共 37 条
  • [1] Characterization of Primary Cilia in Normal Fallopian Tube Epithelium and Serous Tubal Intraepithelial Carcinoma
    Abdelhamed, Zakia A.
    Ryan, Thomas A.
    Fuller, Martin
    Coulson-Gilmer, Camilla
    Abdelmottaleb, Dina I.
    Wang, Tian-Li
    Kaun, Jen-Chun
    Wang, Peiyi
    Hutson, Richard
    Wilkinson, Nafisa
    Bell, Sandra M.
    Johnson, Colin A.
    [J]. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2018, 28 (08) : 1535 - 1544
  • [2] Decreased FOXJ1 expression and its ciliogenesis programme in aggressive ependymoma and choroid plexus tumours
    Abedalthagafi, Malak S.
    Wu, Michael P.
    Merrill, Parker H.
    Du, Ziming
    Woo, Terri
    Sheu, Shu-Hsien
    Hurwitz, Shelley
    Ligon, Keith L.
    Santagata, Sandro
    [J]. JOURNAL OF PATHOLOGY, 2016, 238 (04) : 584 - 597
  • [3] Progress in cancer survival, mortality, and incidence in seven high-income countries 1995-2014 (ICBP SURVMARK-2): a population-based study
    Arnold, Melina
    Rutherford, Mark J.
    Bardot, Aude
    Ferlay, Jacques
    Andersson, Therese M-L
    Myklebust, Tor Age
    Tervonen, Hanna
    Thursfield, Vicky
    Ransom, David
    Shack, Lorraine
    Woods, Ryan R.
    Turner, Donna
    Leonfellner, Suzanne
    Ryan, Susan
    Saint-Jacques, Nathalie
    De, Prithwish
    McClure, Carol
    Ramanakumar, Agnihotram V.
    Stuart-Panko, Heather
    Engholm, Gerda
    Walsh, Paul M.
    Jackson, Christopher
    Vernon, Sally
    Morgan, Eileen
    Gavin, Anna
    Morrison, David S.
    Huws, Dyfed W.
    Porter, Geoff
    Butler, John
    Bryant, Heather
    Currow, David C.
    Hiom, Sara
    Parkin, D. Max
    Sasieni, Peter
    Lambert, Paul C.
    Moller, Bjorn
    Soerjomataram, Isabelle
    Bray, Freddie
    [J]. LANCET ONCOLOGY, 2019, 20 (11) : 1493 - 1505
  • [4] Geminin deploys multiple mechanisms to regulate Cdt1 before cell division thus ensuring the proper execution of DNA replication
    Ballabeni, Andrea
    Zamponi, Raffaella
    Moore, Jodene K.
    Helin, Kristian
    Kirschner, Marc W.
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2013, 110 (30) : E2848 - E2853
  • [5] Association Between BRCA1 and BRCA2 Mutations and Survival in Women With Invasive Epithelial Ovarian Cancer
    Bolton, Kelly L.
    Chenevix-Trench, Georgia
    Goh, Cindy
    Sadetzki, Siegal
    Ramus, Susan J.
    Karlan, Beth Y.
    Lambrechts, Diether
    Despierre, Evelyn
    Barrowdale, Daniel
    McGuffog, Lesley
    Healey, Sue
    Easton, Douglas F.
    Sinilnikova, Olga
    Benitez, Javier
    Garcia, Maria J.
    Neuhausen, Susan
    Gail, Mitchell H.
    Hartge, Patricia
    Peock, Susan
    Frost, Debra
    Evans, Gareth
    Eeles, Rosalind
    Godwin, Andrew K.
    Daly, Mary B.
    Kwong, Ava
    Ma, Edmond S. K.
    Lazaro, Conxi
    Blanco, Ignacio
    Montagna, Marco
    D'Andrea, Emma
    Nicoletto, Maria Ornella
    Johnatty, Sharon E.
    Krueger, Susanne
    Jensen, Allan
    Hogdall, Estrid
    Goode, Ellen L.
    Fridley, Brooke L.
    Loud, Jennifer T.
    Greene, Mark H.
    Mai, Phuong L.
    Chetrit, Angela
    Lubin, Flora
    Hirsh-Yechezkel, Galit
    Glendon, Gord
    Andrulis, Irene L.
    Toland, Amanda E.
    Senter, Leigha
    Gore, Martin E.
    Gourley, Charlie
    Michie, Caroline O.
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2012, 307 (04): : 382 - 390
  • [6] mRNAs, proteins and the emerging principles of gene expression control
    Buccitelli, Christopher
    Selbach, Matthias
    [J]. NATURE REVIEWS GENETICS, 2020, 21 (10) : 630 - 644
  • [7] Combined CCNE1 high-level amplification and overexpression is associated with unfavourable outcome in tubo-ovarian high-grade serous carcinoma
    Chan, Angela M. Y.
    Enwere, Emeka
    McIntyre, John B.
    Wilson, Holly
    Nwaroh, Chidera
    Wiebe, Nicholas
    Ou, Young
    Liu, Shuhong
    Wiedemeyer, Katharina
    Rambau, Peter F.
    Grevers, Xin
    Morris, Donald G.
    Neri, Paola
    Gilks, C. Blake
    Visser, Frank
    Le, Nhu
    Luo, Li
    Cook, Linda S.
    Kobel, Martin
    [J]. JOURNAL OF PATHOLOGY CLINICAL RESEARCH, 2020, 6 (04) : 252 - 262
  • [8] Single cell transcriptomes of normal endometrial derived organoids uncover novel cell type markers and cryptic differentiation of primary tumours
    Cochrane, Dawn R.
    Campbell, Kieran R.
    Greening, Kendall
    Ho, Germain C.
    Hopkins, James
    Bui, Minh
    Douglas, J. Maxwell
    Sharlandjieva, Vassilena
    Munzur, Asli D.
    Lai, Daniel
    DeGrood, Maya
    Gibbard, Evan W.
    Leung, Samuel
    Boyd, Niki
    Cheng, Angela S.
    Chow, Christine
    Lim, Jamie L. P.
    Farnell, David A.
    Kommoss, Stefan
    Kommoss, Friedrich
    Roth, Andrew
    Hoang, Lien
    McAlpine, Jessica N.
    Shah, Sohrab P.
    Huntsman, David G.
    [J]. JOURNAL OF PATHOLOGY, 2020, 252 (02) : 201 - 214
  • [9] Veliparib with First-Line Chemotherapy and as Maintenance Therapy in Ovarian Cancer
    Coleman, R. L.
    Fleming, G. F.
    Brady, M. F.
    Swisher, E. M.
    Steffensen, K. D.
    Friedlander, M.
    Okamoto, A.
    Moore, K. N.
    Ben-Baruch, N. Efrat
    Werner, T. L.
    Cloven, N. G.
    Oaknin, A.
    DiSilvestro, P. A.
    Morgan, M. A.
    Nam, J. -H.
    Leath, C. A., III
    Nicum, S.
    Hagemann, A. R.
    Littell, R. D.
    Cella, D.
    Baron-Hay, S.
    Garcia-Donas, J.
    Mizuno, M.
    Bell-McGuinn, K.
    Sullivan, D. M.
    Bach, B. A.
    Bhattacharya, S.
    Ratajczak, C. K.
    Ansell, P. J.
    Dinh, M. H.
    Aghajanian, C.
    Bookman, M. A.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2019, 381 (25) : 2403 - 2415
  • [10] Incidental Nonuterine High-grade Serous Carcinomas Arise in the Fallopian Tube in Most Cases Further Evidence for the Tubal Origin of High-grade Serous Carcinomas
    Gilks, C. Blake
    Irving, Julie
    Koebel, Martin
    Lee, Chenghan
    Singh, Naveena
    Wilkinson, Nafisa
    McCluggage, W. Glenn
    [J]. AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2015, 39 (03) : 357 - 364